Home > Signaling Pathways>Others>Others 6>Mitiglinide (S21403)
Mitiglinide (S21403)

This product is for research use only, not for human use. We do not sell to patients.

Mitiglinide (S21403)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
50mg$503-6 Days
100mg$703-6 Days
250mg$1003-6 Days
500mg$1503-6 Days
1g$2503-6 Days
2g$4503-6 Days

Cat #: V2038 CAS #: 145375-43-5 Purity ≥ 98%

Description: Mitiglinide (also known as KAD-1229; S21403) is a Potassiun Channel blocker that is used as a blood glucose-lowering drug, it stimulates insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide may be potential useful for the treatment of type 2 diabetes.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)315.41
Molecular FormulaC19H24NO3
CAS No.145375-43-5
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility In VitroDMSO: <1 mg/mL
Water:<1 mg/mL
Ethanol: 2 mg/mL (2.99 mM)
SMILES CodeO=C(O)[C@@H](CC1=CC=CC=C1)CC(N2C[C@]3([H])CCCC[C@]3([H])C2)=O
SynonymsKAD-1229; KAD 1229; KAD1229; S 21403; Mitiglinide; Glufast.
ProtocolIn VitroIn vitro activity: Mitiglinide (KAD-1229; S21403) is a drug for the treatment of type 2 diabetes; it is a highly selective KATP channel antagonist. IC50 value: Target: KATP channel Mitiglinide is a hypoglycemic agent that closes adenosine triphosphate (ATP)-sensitive potassium channels (KATP channel s) in the pancreatic β-islet cells. Mitiglinide stimulates insulin secretion by stimulating Ca2+ influx.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM3.1705 mL15.8524 mL31.7048 mL63.4095 mL
5mM0.6341 mL3.1705 mL6.3410 mL12.6819 mL
10mM0.3170 mL1.5852 mL3.1705 mL6.3410 mL
20mM0.1585 mL0.7926 mL1.5852 mL3.1705 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.